Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darunavir/ritonavir or lopinavir/ritonavir monotherapy versus standard of care in virologically suppressed adults with HIV
2012-004556-11Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Oct 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Darunavir/ritonavir monotherapy, Lopinavir/ritonavir monotherapy and Standard of care (3 arms). Started Oct 2012; status: completed.
02
Drugs
darunavirlopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2012-004556-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004556-11.